ALPHARETTA, Ga., Sept. 8, 2015 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) announced today the closing of its offer to exchange all of its outstanding $250 million of 6.25 percent Senior Notes due 2022 (the "old notes") for an equal principal amount of newly issued 6.25 percent Senior Notes due 2022, which have been registered under the Securities Exchange Act of 1933, as amended (the "new notes").
The exchange offer expired at 5 p.m. ET on Sept. 1, with $250 million in aggregate principal amount of the old notes, representing 100 percent of the old notes, having been validly tendered in exchange for an equal amount of new notes.
This press release is not an offer to buy or sell or the solicitation of an offer to buy or sell any of the securities described herein, nor shall there be any offer, solicitation or sale of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The exchange offer was made only pursuant to the exchange offer documents that were distributed to holders of the old notes, including the prospectus dated Aug. 4 and the related letter of transmittal.
About Halyard Health
Halyard Health (NYSE: HYH) is a medical technology company focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today's most important healthcare needs, such as preventing healthcare-associated infections and reducing the use of narcotics while helping patients move from surgery to recovery. Halyard's business segments - Surgical and Infection Prevention (S&IP) and Medical Devices - develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.
SOURCE Halyard Health, Inc.